Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Intravenous and Intranasal BMSCThis is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/ Sclérose latérale amyotrophique Non applicable Thérapie cellulaire United States, United Arab Emirates À vérifier
Intravenous and Intranasal BMSCThis is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/ Sclérose latérale amyotrophique Non applicable Thérapie cellulaire United States, United Arab Emirates À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Intravenous and Intranasal BMSC Sclérose latérale amyotrophique Non applicable NCT02795052 NEST — Neurologic Stem Cell Treatment Study RECRUITING

Publications

3
MoléculeIndication / populationTitreJournalDate
Intravenous and Intranasal BMSC Treatment of the bone marrow stromal stem cell supernatant by nasal administration-a new approach to EAE therapy. Stem cell research & therapy
Intravenous and Intranasal BMSC Analysis of the expression changes of IL-17+ γδ T cells and Treg cells in bone marrow mesenchymal stem cells targeted therapy for allergic rhinitis. European review for medical and pharmacological sciences
Intravenous and Intranasal BMSC Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models. Frontiers in pharmacology